ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) told investors that its chief scientific officer Randolph Corteling will speak at the Advanced Therapies 2023 conference in London, taking place on 14 March to 15 March.
A presentation will be highlight the advantages of customisable stem-cell derived exosome drug delivery platform (CustomEXTM) over current technologies, ReNeuron said in a statement.